← Open Payments lookup

KATHLEEN BUI: Open Payments

NPI 1801539697 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,030 in 50 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $564 · 2025 $1,030

Food & beverage: $1,030
CompanyPaymentsAmount
ABBVIE INC.22$339
Janssen Biotech, Inc.5$184
Madrigal Pharmaceuticals9$161
Takeda Pharmaceuticals U.S.A., Inc.3$94
GENZYME CORPORATION2$55
Lilly USA, LLC1$32
Regeneron Healthcare Solutions, Inc.1$29
Aimmune Therapeutics, Inc.1$26
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$23
Braintree Laboratories, Inc.1$22

Products named: RINVOQ, TREMFYA, REZDIFFRA, EOHILIA, DUPIXENT, SKYRIZI, LINZESS, OMVOH.

Industry payments across TX — which companies pay providers there.